A Neuroleptic Malignant Syndrome Without Rigidity
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Neuroleptic malignant syndrome (NMS) is an uncommon but potentially lethal idiosyncratic reaction which may emerge in the aftermath of the treatments with neuroleptics demonstrating itself with the symptoms of altered consciousness, high fever, impaired autonomic functions, and muscle rigidity. Although various risk factors have been identified for NMS, its etiology is not completely known. The mortality and morbidity related with NMS could be reduced by early diagnosis, interruption of the neuroleptics used within a short period and aggressive treatment. Our case is different from general NMS cases due to lack of rigidity. A NMS case which developed within a short time in the aftermath of multiple antipsychotic use and wherein no rigidity was observed shall be discussed in this case report.
Abstract
Neuroleptic malignant syndrome (NMS) is an uncommon but potentially lethal idiosyncratic reaction which may emerge in the aftermath of the treatments with neuroleptics demonstrating itself with the symptoms of altered consciousness, high fever, impaired autonomic functions, and muscle rigidity. Although various risk factors have been identified for NMS, its etiology is not completely known. The mortality and morbidity related with NMS could be reduced by early diagnosis, interruption of the neuroleptics used within a short period and aggressive treatment. Our case is different from general NMS cases due to lack of rigidity. A NMS case which developed within a short time in the aftermath of multiple antipsychotic use and wherein no rigidity was observed shall be discussed in this case report.
참고문헌 (20)
- Nielsen J, "Atypical neuroleptic malignant syndrome caused by olanzapine", Acta Psychiatr Scand, 112, pp.238~240 (2005)[DOI]
- Semiz UB, "Neuroleptic Malignant Syndrome;Schizophrenia. 4th Edition", pp.167~176 (2009), Incekara Matbaacilik
- Tural U, "Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death", Psychiatry Clin Neurosci, 64, pp.79~87 (2010)[DOI]
- Sarkar P, "Prevalence of neuroleptic malignant syndrome in 672 consecutive male in patients", Indian J Psychiatry, 51, pp.202~205 (2009)
- Chandran GJ, "Neuroleptic malignant syndrome: case report and discussion", CMAJ, 169, pp.439~442 (2003)
- Khaldi S, "Neuroleptic malignant syndrome and atypical antipsychotics: a brief review", Encephale, 34, pp.618~624 (2008)[DOI]
- Ozturk MO, "Mental Health and Disorders 13th Edition" (2015), Nobel Tip Kitabevleri
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders (5th Ed.)" (2013)
- Kamisli O, "Aripiprazole and neuroleptic malignant syndrome in an adolescent patient: a case report", Arch Neuropsychiatry, 47, pp.260~262 (2010)
- Reulbach U, "Managing an effective treatment for neuroleptic malignant syndrome", Crit Care, 11, pp.R4~ (2007)[DOI]
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders. Fourth Ed., Text Revision" (2000)
- Nierenberg D, "Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome", Clin Pharmacol Ther, 50, pp.580~586 (1991)[DOI]
- Benazzi F, "Neuroleptic malignant syndrome without rigidity", Ital J Neurol Sci, 12, pp.121~ (1991)[DOI]
- Farver DK, "Neuroleptic malignant syndrome induced by a typical antipsychotic", Expert Opin Drug Saf, 2, pp.21~35 (2003)[DOI]
- Ananth J, "Neuroleptic malignant syndrome and atypical antipsychotic drugs", J Clin Psychiatry, 65, pp.464~470 (2004)[DOI]
- Seitz DP, "Diagnostic uncertainty in a case of neuroleptic malignant syndrome", Can J Emerg Med, 7, pp.266~272 (2005)
- Altindag A, "Neuroleptic malignant syndrome in two brothers with mental retardation", Bull Clin Psychopharm, 14, pp.150~153 (2004)
- Harmanci H, "Fatal Neuroleptic Malignant Syndrome with Single Dose Olanzapine: A Case Report", Dusunen Adam, 26, pp.106~ (2013)
- Rajamani B, "Neuroleptic malignant syndrome", J Family Med Prim Care, 5, pp.178~180 (2016)[DOI]
- Ho-Dong Choi, "A Case of Catatonia and Neuroleptic Malignant Syndrome Probably Associated with Antipsychotic in Korea", PSYCHIATRY INVESTIGATION, 8(2), pp.174~177 (2011), 대한신경정신의학회